Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RIGL

Rigel Pharmaceuticals

May 15 • 09:53AM ET

31.19

-0.73 -2.27 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT NRIX KROS TGTX RLAY

| Held by: XBI AVUV VTI IWM VXF IWO IBB CALF JSMD FESM

Scroll to Statements

Index	RUT	P/E	1.67	EPS (ttm)	18.72	Insider Own	3.07%	Shs Outstand	18.48M	Perf Week	19.80%
Market Cap	577.17M	Forward P/E	7.13	EPS next Y	4.38	Insider Trans	-0.70%	Shs Float	17.93M	Perf Month	-1.81%
Enterprise Value	476.21M	PEG	-	EPS next Q	0.21	Inst Own	92.73%	Short Float	21.95%	Perf Quarter	-9.11%
Income	364.23M	P/S	1.93	EPS this Y	-83.84%	Inst Trans	6.17%	Short Ratio	10.02	Perf Half Y	-21.90%
Sales	299.77M	P/B	1.44	EPS next Y	38.98%	ROA	107.04%	Short Interest	3.94M	Perf YTD	-27.17%
Book/sh	21.64	P/C	3.93	EPS next 5Y	-	ROE	174.08%	52W High	52.24 -40.29%	Perf Year	58.03%
Cash/sh	7.93	P/FCF	7.28	EPS past 3/5Y	- -	ROIC	87.74%	52W Low	18.12 72.11%	Perf 3Y	132.80%
Dividend Est.	-	EV/EBITDA	3.75	Sales past 3/5Y	34.76% 22.06%	Gross Margin	93.39%	Volatility	7.21% 5.39%	Perf 5Y	-15.92%
Dividend TTM	-	EV/Sales	1.59	EPS Y/Y TTM	854.73%	Oper. Margin	41.56%	ATR (14)	1.78	Perf 10Y	35.63%
Dividend Ex-Date	-	Quick Ratio	2.48	Sales Y/Y TTM	47.61%	Profit Margin	121.51%	RSI (14)	57.57	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	2.62	EPS Q/Q	-30.22%	SMA20	5.34%	Beta	1.21	Target Price	53.20
Payout	0.00%	Debt/Eq	0.11	Sales Q/Q	10.28%	SMA50	9.08%	Rel Volume	1.74	Prev Close	31.92
Employees	174	LT Debt/Eq	0.04	Earnings	May 05 AMC	SMA200	-9.83%	Avg Volume	392.83K	Price	31.19
IPO	Nov 29, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-44.67% -5.73%	Trades		Volume	70,797	Change	-2.27%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)